Joseph C. Papa
| Joseph C. Papa | |
|---|---|
| Born | 1955/1956 (age 61–62) Connecticut |
| Residence | New Jersey |
| Nationality | American |
| Alma mater |
University of Connecticut Northwestern University |
| Salary | US$62.7 million (8 months in 2016) |
| Title | Chairman and CEO, Valeant Pharmaceuticals |
| Term | May 2016- |
| Predecessor | J. Michael Pearson |
| Board member of | Valeant, Smith & Nephew |
Joseph C. Papa (born 1955/56) is an American businessman, the chairman and chief executive officer (CEO) of Valeant Pharmaceuticals from May 2, 2016 succeeding J. Michael Pearson.
Papa received a bachelor's degree in Pharmacy from the University of Connecticut in 1978, and an MBA degree in Marketing and Finance from Northwestern University's Kellogg Graduate School of Management in 1983.
Prior to joining Valeant, Papa was the chairman and CEO of Perrigo, an American manufacturer of private label over-the-counter pharmaceuticals, from 2006 to 2016. From December 2004 to October 2006, Papa was chairman and CEO of the pharmaceutical and technologies services of Cardinal Health, an Ohio health care services company. From 2001 to 2004, he was president and chief operating officer of Watson Pharmaceuticals, Inc. He has also worked at Novartis and Pharmacia/Searle, where he launched the medications Celebrex, Diovan, and Lotrel.
In March 2017, it was reported that Papa received US$62.7 million in total compensation for his first eight months of work in 2016.
...
Wikipedia